Experts Matter. Find Yours.Connect for media, speaking, professional opportunities & more.Select a tabExpertise for "drug resistance“FiltersFiltersTop TopicsCompaniesCountriesMediaTop TopicsLife SciencesAlzheimer's DiseaseBiopharmaceuticalsBiotechnologyBioterrorismBird FluBlood-Brain BarrierBusiness Development & PartnershipsCOVID-19 (Omicron, XBB, etc.)CancerCell BioenergeticsClinical TrialsCommercializationCompanion DiagnosticsDisaster PreparednessDrug DesignDrug DevelopmentDrug Resistance / SuperbugsEpidemiologyGut HealthHealth DisparitiesHealth InnovationHealth TechnologiesInfectious DiseaseInfectious DiseasesLong COVIDMarketing & Corporate StrategyMedical GeneticsMedical Guideline and PolicyMedicinal ChemistryMicrobiome Mitochondrial FunctionMolecular BiologyMolecular Cell BiologyMolecular DiagnosticsMonkeypoxNanoformulationsNanomedicineNeurological Disorders (Multiple Sclerosis, Pain Management)OncologyOncology and Cancer ResearchOne HealthParkinson's DiseasePharmaceutical IndustryPolicy AnalysisPost-Pandemic Mental Health TrendsPrecision TherapeuticsProgram ImplementationProject and Program ManagementPsychedelic MedicineShow All +CompaniesAston UniversityMaRS InnovationShiruy, Inc | University of Toronto, Faculty of MedicineTexas Christian UniversityUniversity of ConnecticutX-Biotix TherapeuticsCountriesUnited StatesCanadaUnited KingdomMediaPodchaserPhotosVideoPublicationsDocuments/SlidesPreviousNextShowing 3590 to 6 of 6 Results
